<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04750525</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-20-1032 (Experiment 1)</org_study_id>
    <nct_id>NCT04750525</nct_id>
  </id_info>
  <brief_title>A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation (Experiment 1)</brief_title>
  <official_title>A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation (Experiment 1)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Disability, Independent Living, and Rehabilitation Research</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effectiveness of innovative intervention of&#xD;
      breathing controlled electrical stimulation (BreEStim) and conventional electrical&#xD;
      stimulation (EStim) in management of neuropathic phantom limb pain in patients after limb&#xD;
      amputation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2, 2021</start_date>
  <completion_date type="Anticipated">August 21, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 21, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Pain as measured by the visual analog scale (VAS). Scores are recorded from 0 to10.</measure>
    <time_frame>Baseline, 5 minutes after intervention</time_frame>
    <description>Scores are recorded from 0 to 10 with 0 being &quot;no pain&quot; and 10 being &quot;worst pain.&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in sensation measured by Electrical sensation detection threshold (EDT)</measure>
    <time_frame>Baseline, 5 minutes after intervention</time_frame>
    <description>This is self-reported by the subjects as soon as they first sense the electrical current.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in pain measured by Electrical pain detection threshold (EPT)</measure>
    <time_frame>Baseline, 5 minutes after intervention</time_frame>
    <description>This is self-reported by the subjects at the first sensation of pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Heart Rate Variability (HRV) measured by electrocardiogram (ECG)</measure>
    <time_frame>Baseline, 5 minutes after intervention</time_frame>
    <description>HRV is a measure of the variation in time between each heartbeat. We use HRV to identify the autonomic nervous system changes after intervention treatment.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">14</enrollment>
  <condition>Pain Management</condition>
  <arm_group>
    <arm_group_label>BreEStim 120, then EStim 120</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BreEStim is voluntary breathing controlled transcutaneous electrical nerve stimulation. EStim is transcutaneous electrical nerve stimulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EStim 120, then BreEStim 120</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BreEStim is voluntary breathing controlled transcutaneous electrical nerve stimulation. EStim is transcutaneous electrical nerve stimulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BreEStim</intervention_name>
    <description>120 BreEStim stimuli will applied for about 10 minutes.</description>
    <arm_group_label>BreEStim 120, then EStim 120</arm_group_label>
    <arm_group_label>EStim 120, then BreEStim 120</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EStim</intervention_name>
    <description>120 EStim stimuli will applied for about 10 minutes.</description>
    <arm_group_label>BreEStim 120, then EStim 120</arm_group_label>
    <arm_group_label>EStim 120, then BreEStim 120</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  has phantom limb pain (PLP) after amputation of one limb, upper or lower limb;&#xD;
&#xD;
          -  has chronic pain, &gt;3 months;&#xD;
&#xD;
          -  is stable on oral pain medications at least two weeks. (patients are allowed to&#xD;
             continue their pain medications, i.e., no change in pain medications.)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  currently adjusting oral pain medications for their PLP;&#xD;
&#xD;
          -  has pain, but not PLP (e.g., from inflammation at the incision wound of the residual&#xD;
             limb);&#xD;
&#xD;
          -  has a pacemaker, or other metal and/or implanted devices;&#xD;
&#xD;
          -  has cognitive impairment from brain injury or are not able to follow commands, or to&#xD;
             give consent;&#xD;
&#xD;
          -  has amputation in multiple limbs;&#xD;
&#xD;
          -  have asthma or other pulmonary diseases;&#xD;
&#xD;
          -  are not medically stable;&#xD;
&#xD;
          -  have preexisting psychiatric disorders;&#xD;
&#xD;
          -  alcohol or drug abuse;&#xD;
&#xD;
          -  have a history of seizures/Epilepsy, or taking benzodiazepines, anticonvulsants, and&#xD;
             antidepressants.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sheng Li, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sheng Li, MD, PhD</last_name>
    <phone>(713) 797-7125</phone>
    <email>sheng.li@uth.tmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shengai Li, MS</last_name>
    <phone>713-797-7561</phone>
    <email>shengai.li@uth.tmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Texas Health Science Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shengai Li, MD, PhD</last_name>
      <phone>713-500-5874</phone>
      <email>sheng.li@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Shengai Li, MS</last_name>
      <phone>(713)797-7561</phone>
      <email>shengai.li@uth.tmc.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 10, 2021</study_first_submitted>
  <study_first_submitted_qc>February 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2021</study_first_posted>
  <last_update_submitted>May 21, 2021</last_update_submitted>
  <last_update_submitted_qc>May 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Sheng Li</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Phantom Limb Pain</keyword>
  <keyword>BreEStim</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phantom Limb</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

